Norway to start breast screening by 2003:
This article was originally published in Clinica
Executive Summary
Norway aims to offer breast cancer screening to every woman aged between 50 and 69 by 2003 as part of a five-year plan to improve the country's cancer care. The government has earmarked funds of NKr2 billion ($260 million) to expand the range of cancer services offered throughout the country. The number of radiotherapy machines at Norwegian hospitals will increase from 22 to 36, centres specialising in hereditary cancers will be set up and projects to assess the value of mass screening for prostate and colorectal cancers will be established.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.